RxDoctor Payments Data

Gordon Mao, MD

Neurological Surgery · Indianapolis, INNPI 1063854651

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Merck at 60.0% of the total.

$10,798in general payments, 2019–2025

Across 64 payments — averaging $168.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$6K
  • Medtronic$3K
  • Globus Medical$793
  • Icotec Medical Inc.$316
  • Johnson & Johnson$231
  • Microvention, Inc.$144
  • plus $189 from 6 others

What the payments were for

  • Consulting fees$6,46060%
  • Travel & lodging$1,56715%
  • Food & beverage$2,73325%
  • Education$380%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck10$6,478
Medtronic(2 entities)33$2,647
Globus Medical5$793
Icotec Medical Inc.2$316
Johnson & Johnson7$231
Microvention, Inc.1$144
Aesculap, Inc.1$63
Kuros Biosciences USA, Inc1$62
CSL Behring1$20
Synaptive Medical Inc.1$17
Bioventus LLC1$15
Biocomposites Inc1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,798 in reported general payments places this provider in the 70th percentile of 112 neurological surgery providers in Indiana.

See all neurological surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$190,181
Medicare patients
191
Services billed
561

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methocarbamol104$1,243
Gabapentin91$993
Cyclobenzaprine Hcl11$316
Methylprednisolone19$126
Oxycodone Hcl26$121

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →